{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:30:59Z","timestamp":1777962659830,"version":"3.51.4"},"reference-count":41,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2020.11637","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T09:38:42Z","timestamp":1589794722000},"page":"868-876","source":"Crossref","is-referenced-by-count":11,"title":["Antitumor immunity targeting fibroblast activation protein\u2011\u03b1 in a mouse Lewis lung carcinoma model"],"prefix":"10.3892","volume":"20","author":[{"given":"Junping","family":"Xie","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyang","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laishui","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanyu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linxia","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolin","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengying","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2020,5,18]]},"reference":[{"key":"key20200714152025_b1-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3892\/ijo.2012.1475","article-title":"Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells","volume":"41","author":"Lai","year":"2012","journal-title":"Int J Oncol"},{"key":"key20200714152025_b2-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1089\/ars.2010.3727","article-title":"Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness","volume":"14","author":"Giannoni","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"key20200714152025_b3-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1158\/2326-6066.CIR-16-0011","article-title":"Can targeting stroma pave the way to enhanced antitumor immunity and immunotherapy of solid tumors?","volume":"4","author":"Pur\u00e9","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"key20200714152025_b4-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fcell.2019.00060","article-title":"Cancer-associated fibroblasts build and secure the tumor microenvironment","volume":"7","author":"Liu","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"key20200714152025_b5-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ccr.2010.04.018","article-title":"Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner","volume":"17","author":"Erez","year":"2010","journal-title":"Cancer Cell"},{"key":"key20200714152025_b6-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/cas.12584","article-title":"Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine","volume":"106","author":"Ohshio","year":"2015","journal-title":"Cancer Sci"},{"key":"key20200714152025_b7-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"R187","DOI":"10.1530\/ERC-12-0085","article-title":"The reactive stroma microenvironment and prostate cancer progression","volume":"19","author":"Barron","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"key20200714152025_b8-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1101\/gad.279737.116","article-title":"Carcinoma-associated fibroblasts: Orchestrating the composition of malignancy","volume":"30","author":"Gascard","year":"2016","journal-title":"Genes Dev"},{"key":"key20200714152025_b9-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41571-018-0007-1","article-title":"Targeting the tumour stroma to improve cancer therapy","volume":"15","author":"Valkenburg","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"key20200714152025_b10-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1006\/excr.2000.5133","article-title":"Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation","volume":"264","author":"Elenbaas","year":"2001","journal-title":"Exp Cell Res"},{"key":"key20200714152025_b11-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2741\/3613","article-title":"Cancer associated fibroblasts (CAFs) in tumor microenvironment","volume":"15","author":"Xing","year":"2010","journal-title":"Front Biosci (Landmark Ed)"},{"key":"key20200714152025_b12-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nature03096","article-title":"Stromal fibroblasts in cancer initiation and progression","volume":"432","author":"Bhowmick","year":"2004","journal-title":"Nature"},{"key":"key20200714152025_b13-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1172\/JCI38988","article-title":"Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice","volume":"119","author":"Santos","year":"2009","journal-title":"J Clin Invest"},{"key":"key20200714152025_b14-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.febslet.2006.01.087","article-title":"Peptide substrate profiling defines fibroblast activation protein as an endopeptidase of strict Gly(2)-Pro(1)-cleaving specificity","volume":"580","author":"Edosada","year":"2006","journal-title":"FEBS Lett"},{"key":"key20200714152025_b15-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"7437","DOI":"10.1074\/jbc.M511112200","article-title":"Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity","volume":"281","author":"Edosada","year":"2006","journal-title":"J Biol Chem"},{"key":"key20200714152025_b16-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1021\/ml300410d","article-title":"Selective inhibitors of fibroblast activation protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine scaffold","volume":"4","author":"Jansen","year":"2013","journal-title":"ACS Med Chem Lett"},{"key":"key20200714152025_b17-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"4598","DOI":"10.1021\/bi062227y","article-title":"Ala657 and conserved active site residues promote fibroblast activation protein endopeptidase activity via distinct mechanisms of transition state stabilization","volume":"46","author":"Meadows","year":"2007","journal-title":"Biochemistry"},{"key":"key20200714152025_b18-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1158\/1078-0432.CCR-07-5211","article-title":"Effective immunoconjugate therapy in cancer models targeting a serine protease of tumor fibroblasts","volume":"14","author":"Ostermann","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20200714152025_b19-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2121-15-16","article-title":"FAP-\u03b1 (Fibroblast activation protein-\u03b1) is involved in the control of human breast cancer cell line growth and motility via the FAK pathway","volume":"15","author":"Jia","year":"2014","journal-title":"BMC Cell Biol"},{"key":"key20200714152025_b20-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nm0797-808","article-title":"Sensitivity and reproducibility in adenoviral infectious titer determination","volume":"3","author":"Nyberg-Hoffman","year":"1997","journal-title":"Nat Med"},{"key":"key20200714152025_b21-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.lungcan.2009.07.007","article-title":"Antitumor effects of murine bone marrow-derived dendritic cells infected with xenogeneic livin alpha recombinant adenoviral vectors against lewis lung carcinoma","volume":"68","author":"Xie","year":"2010","journal-title":"Lung Cancer"},{"key":"key20200714152025_b22-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"11156","DOI":"10.1158\/0008-5472.CAN-05-2805","article-title":"Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts","volume":"65","author":"Lee","year":"2005","journal-title":"Cancer Res"},{"key":"key20200714152025_b23-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1038\/s41388-018-0275-3","article-title":"Pro-tumorigenic roles of fibroblast activation protein in cancer: Back to the basics","volume":"37","author":"Pur\u00e9","year":"2018","journal-title":"Oncogene"},{"key":"key20200714152025_b24-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1126\/science.1840703","article-title":"A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma","volume":"254","author":"van der Bruggen","year":"1991","journal-title":"Science"},{"key":"key20200714152025_b25-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1084\/jem.20072016","article-title":"Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness","volume":"205","author":"Willimsky","year":"2008","journal-title":"J Exp Med"},{"key":"key20200714152025_b26-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/nri1961","article-title":"Interferons, immunity and cancer immunoediting","volume":"6","author":"Dunn","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"key20200714152025_b27-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.4049\/jimmunol.177.2.1338","article-title":"A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: Spontaneous priming and efficient boosting by vaccination","volume":"177","author":"Speiser","year":"2006","journal-title":"J Immunol"},{"key":"key20200714152025_b28-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"6169","DOI":"10.4049\/jimmunol.175.9.6169","article-title":"Tumor progression can occur despite the induction of very high levels of self\/tumor antigen-specific CD8 + T cells in patients with melanoma","volume":"175","author":"Rosenberg","year":"2005","journal-title":"J Immunol"},{"key":"key20200714152025_b29-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"8947","DOI":"10.1073\/pnas.0703395104","article-title":"Vaccination with NY-ESO-1 protein and CpG in montanide induces integrated antibody\/Th1 responses and CD8 T cells through cross-priming","volume":"104","author":"Valmori","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200714152025_b30-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"7235","DOI":"10.1073\/pnas.87.18.7235","article-title":"Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers","volume":"87","author":"Garin-Chesa","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200714152025_b31-ol-0-0-11637","first-page":"10","article-title":"Characterization of cancer stroma markers: In silico analysis of an mRNA expression database for fibroblast activation protein and endosialin","volume":"5","author":"Dolznig","year":"2005","journal-title":"Cancer Immun"},{"key":"key20200714152025_b32-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40425-017-0230-9","article-title":"Current approaches to increase CAR T cell potency in solid tumors: Targeting the tumor microenvironment","volume":"5","author":"Scarf\u00f2","year":"2017","journal-title":"J Immunother Cancer"},{"key":"key20200714152025_b33-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","article-title":"Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion","volume":"121","author":"Orimo","year":"2005","journal-title":"Cell"},{"key":"key20200714152025_b34-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1023\/A:1023055600919","article-title":"Seprase complexes in cellular invasiveness","volume":"22","author":"Chen","year":"2003","journal-title":"Cancer Metastasis Rev"},{"key":"key20200714152025_b35-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/S1367-5931(03)00084-X","article-title":"Prolyl peptidases: A serine protease subfamily with high potential for drug discovery","volume":"7","author":"Rosenblum","year":"2003","journal-title":"Curr Opin Chem Biol"},{"key":"key20200714152025_b36-ol-0-0-11637","first-page":"44","article-title":"Stromal antigen targeting by a humanised monoclonal antibody: An early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer","volume":"26","author":"Hofheinz","year":"2003","journal-title":"Onkologie"},{"key":"key20200714152025_b37-ol-0-0-11637","first-page":"1639","article-title":"A phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer","volume":"9","author":"Scott","year":"2003","journal-title":"Clin Cancer Res"},{"key":"key20200714152025_b38-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12876-015-0340-0","article-title":"Fibroblast activation protein-\u03b1-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma","volume":"15","author":"Kawase","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"key20200714152025_b39-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1093\/jnci\/djs336","article-title":"Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug","volume":"104","author":"Brennen","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"key20200714152025_b40-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1126\/science.1198345","article-title":"Cancer. Awakening immunity","volume":"330","author":"Schreiber","year":"2010","journal-title":"Science"},{"key":"key20200714152025_b41-ol-0-0-11637","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1126\/science.1195300","article-title":"Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha","volume":"330","author":"Kraman","year":"2010","journal-title":"Science"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T19:36:42Z","timestamp":1597261002000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2020.11637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,18]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,5,18]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2020.11637","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,18]]}}}